Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

CCCA may be caused by both hair traction and an immune response.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Many people diagnosed with androgenic alopecia might actually have hidden scarring or inflammation.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Ingrown hairs are a common feature in scarring alopecias due to follicular damage.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Clinical exams are good for diagnosing some women's hair loss, but lab tests aren't always needed.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Break dancing on the head may cause a type of scarring hair loss that needs early treatment to prevent permanent damage.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.